A61K 38/446
Superoxide dismutase
Official title: {Superoxide dismutase (1.15)}
A61K38/446 (Superoxide dismutase) appears on 253 US grants and 325 published applications in this corpus.
Search patents in A61K- Granted patents
- 253
- Published applications
- 325
- Assignees
- 206
- Inventors
- 613
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 5 | 0 |
| 1990 | 7 | 0 |
| 1991 | 13 | 0 |
| 1992 | 18 | 0 |
| 1993 | 8 | 0 |
| 1994 | 7 | 0 |
| 1995 | 5 | 0 |
| 1996 | 2 | 0 |
| 1997 | 7 | 0 |
| 1998 | 7 | 0 |
| 1999 | 8 | 0 |
| 2000 | 6 | 0 |
| 2001 | 4 | 2 |
| 2002 | 3 | 7 |
| 2003 | 7 | 11 |
| 2004 | 4 | 7 |
| 2005 | 3 | 7 |
| 2006 | 4 | 22 |
| 2007 | 4 | 14 |
| 2008 | 5 | 18 |
| 2009 | 3 | 7 |
| 2010 | 4 | 7 |
| 2011 | 10 | 12 |
| 2012 | 7 | 10 |
| 2013 | 6 | 10 |
| 2014 | 6 | 13 |
| 2015 | 6 | 8 |
| 2016 | 12 | 20 |
| 2017 | 5 | 10 |
| 2018 | 6 | 14 |
| 2019 | 6 | 14 |
| 2020 | 4 | 13 |
| 2021 | 4 | 15 |
| 2022 | 12 | 13 |
| 2023 | 6 | 21 |
| 2024 | 8 | 17 |
| 2025 | 9 | 18 |
| 2026 | 2 | 15 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treatment of pathogen infections formulations and methods for use25 Aug 2026US 12,714,734 B2
- Superoxide dismutase-loaded porous polymersomes as highly efficient antioxidant nanoparticles11 Aug 2026US 12,702,699 B2The Trustees of the University of Pennsylvania
- Composition for preventing, treating, or ameliorating viral infection disease, containing a complex of endoplasmic reticulum (ER) stress inhibitor and reactive oxygen species scavenger as active ingredients16 Dec 2025US 12,496,332 B2Korea University Research and Business Foundation
- Super-oxide dismutase soluble fiber compositions18 Nov 2025US 12,472,240 B2Advance Pharmaceutical, Inc.
- Recombinant AAV vectors useful for reducing immunity against transgene products11 Nov 2025US 12,467,063 B2University of Massachusetts
- Uses of super-oxide dismutase supplements1 Oct 2026US 2026/0295019 A1
- Hair growth and anti-hair greying composition13 Aug 2026US 2026/0232751 A1
- Cytokine storm suppressor, method for using cytokine storm suppressor and screening method9 Jul 2026US 2026/0191910 A1Dexon Pharmaceuticals Inc.
- Gold nanozyme comprising glycol chitosan and gold particles, and pharmaceutical composition for preventing or treating inflammatory bowel disease comprising same9 Jul 2026US 2026/0191938 A1Iucf-Hyu (Industry-University Cooperation Foundation Hanyang University)
- Use of digestion-resistant maltodextrin as a prebiotic digestive, protective and stabilizing modulator enhancing the bioavailabilty barrier25 Jun 2026US 2026/0174686 A1Cellev8 Nutrition, Inc.
Most cited
By later US patents
- Non-immunogenic polypeptides2,007US 4,179,337 A1979
- Intermediates for conjugation of polypeptides with high molecular weight polyalkylene glycols253US 5,283,317 ADDI Pharmaceuticals, Inc. · 1994
- Conjugates of superoxide dismutage coupled to high molecular weight polyalkylene glycols226US 5,468,478 AOxis International, Inc. · 1995
- Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols103US 5,006,333 ADDI Pharmaceuticals, Inc. · 1991
- Therapeutic compositions comprising a mixture of human CuZn superoxide dismutase analogs101US 5,455,029 ABio-Technology General Corp. · 1995